Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 5:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 2,146 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard support Clear all

Conditions: Colorectal Cancer
Interventions: interactive group education, navigation services and engagement of health care providers for referrals, and linkage to care., Education Session on General Health; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 50 Years to 85 Years
Enrollment: 925 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Type 2 Diabetes Treated With Insulin
Interventions: Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS), Continuous Glucose Monitor (CGM) + Usual Care; Other
Lead sponsor: Daniel Chernavvsky, MD; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Hypertension
Interventions: Pharmacists Only (Control Group), Combined Intervention (Pharmacists + CHW Interventions); Other
Lead sponsor: Texas Southern University; Other
Eligibility: 55 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetic Foot Ulcers (DFUs), Venous Leg Ulcers (VLUs), Pressure Ulcers, Surgical Wound Dehiscence (SWD), Chronic Wounds, Undermined and Tunneling Wounds
Interventions: Acellular Porcine-Derived Wound Matrix; Device
Lead sponsor: Reprise Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Coconut Creek, Florida • Tamarac, Florida

Conditions: Bipolar Disorder, Schizophrenia, Major Depressive Disorder, Schizoaffective Disorder, Cardiovascular Disease Risk
Interventions: Life Goals Collaborative Care; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 99 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hypertension
Interventions: Walk Together, Hypertension education; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Interventions: Plant-based diet; Other
Lead sponsor: Jean L. Fry; Other
Eligibility: 30 Years to 55 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Total Knee Replacement
Interventions: Virtual physical therapy rehabilitation program, No intervention; Device · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 4
States / cities: Chapel Hill, North Carolina • Durham, North Carolina • Greensboro, North Carolina + 1 more

Conditions: HIV Infections
Interventions: Enhanced nursing telephone support, Standard care; Behavioral
Lead sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; Network
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 16
States / cities: Birmingham, Alabama • San Diego, California • Chicago, Illinois + 10 more

Conditions: Congenital Heart Disease (CHD)
Interventions: HeartGPS; Other
Lead sponsor: Carelon Research; Other
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 17
States / cities: Phoenix, Arizona • Los Angeles, California • Aurora, Colorado + 13 more

Conditions: Lung Cancer Screening
Interventions: Digital health tool prototype, Control Arm - standard of care; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 50 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: COVID-19
Interventions: COVID-19 Group Problem Solving, Standard of Care, Booster session; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 359 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 1 Diabetes Mellitus
Interventions: Developmental & Technological Demands, Distress Reduction, Nutrition, Set Point, & C:I Ratio, Hypoglycemia management, Minimal Intervention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 6 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Type 1 Diabetes Mellitus, Continuous Glucose Monitor
Interventions: Web-Based Education, Social Support, Standard of Care; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 15 Years to 24 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Obesity
Interventions: TECH+; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 9 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Breast Neoplasms
Interventions: Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane, Everolimus; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 283 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 15
States / cities: La Jolla, California • Los Angeles, California • New Haven, Connecticut + 12 more

Conditions: Spinal Cord Stimulation
Interventions: Spinal Cord Stimulation (SCS) Trial; Procedure
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Addiction
Interventions: Mobile Continuing Care; Behavioral
Lead sponsor: Azusa Pacific University; Other
Eligibility: 12 Years to 24 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Azusa, California

Conditions: Relationship Distress, Mental Health
Interventions: Brief Relationship Checkup (BRC), Co-Located Collaborative Care (CCC); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Canandaigua, New York

Conditions: Ventilator-Induced Lung Injury, Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Preterm Infant
Interventions: Mid frequency ventilation, Standard frequency ventilation; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 3 Days
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: Birmingham, Alabama • Mobile, Alabama

Conditions: Colorectal Neoplasms
Interventions: Nintedanib (BIBF 1120), Placebo, BSC; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 768 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 14
States / cities: Los Angeles, California • New Haven, Connecticut • Plainville, Connecticut + 11 more

Conditions: Spinal Cord Injury, Sleep-disordered Breathing, Spinal Cord Disease, Multiple Sclerosis
Interventions: Best practices PAP + patient Education +ongoing Support and Training, Sleep Education; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Myeloma
Interventions: TempShield Continuous Temperature Monitoring, Standard of Care; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Charlotte, North Carolina • Winston-Salem, North Carolina

Conditions: Behavior, Child
Interventions: BASIS-T, Attention Control (ACC); Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 276 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Korean CRC Screening Study PT13599

Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers

The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.

Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care

Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders

Walk Together Efficacy Trial

Assessing the Impact of a Plant-Based Diet for Diabetes Prevention

Virtual vs. Traditional Physical Therapy Following Total Knee Replacement

Telephone Support to Improve Adherence to Anti-HIV Medications

Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)

Pilot Testing a Web-based Prototype of a Lung Cancer Screening Digital Health Tool

Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19

Supporting Parents of Young Children With Type 1 Diabetes in Closed-Loop System

Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitoring

The mFIT Study (Motivating Families With Interactive Technology)

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Prospective Evaluation of the Optimal SCS Trial Length

Mobile Continuing Care Approach for Youth

Relationship Checkups to Reduce Veteran Suicide Risk

Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome

Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

Treatment of Sleep-disordered Breathing in Patients With SCI

A Randomized Controlled Trial of a Wearable Core Body Temperature Sensor Versus Standard Temperature Monitoring for Early Detection of Cytokine Release Syndrome in Patients Undergoing CAR T-Cell Therapy in an Outpatient Setting

BASIS-T Efficacy Trial